clarithromycin has been researched along with Libman-Sacks Disease in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (9.09) | 18.2507 |
| 2000's | 3 (27.27) | 29.6817 |
| 2010's | 6 (54.55) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Afifi, A; De Lord, D; Rasool, S | 1 |
| Atsumi, T; Fujieda, Y; Iwasaki, N; Kamishima, T; Kono, M; Matsui, Y; Ninagawa, K | 1 |
| Ikeda, SI; Ishii, W; Kinoshita, T; Kishida, D; Kobayashi, C; Kodaira, M; Sato, M; Shimojima, Y; Ueno, KI; Ushiki, A | 1 |
| Mohamed Fuad, Z; Mohd Yusof, NH; Periasamy, P; Shaharir, SS; Sulaiman Sahari, N; Sulong, A; Zukiman, WZHW | 1 |
| Mimori, A; Ohmagari, N; Ueda, Y; Watanabe, K; Yamamoto, K; Yamashita, H | 1 |
| Batra, P; Berger, E; Franks, AG; Ralston, J; Sanchez, MR | 1 |
| Abbey, BV; Jakubovic, HR; Lai, J | 1 |
| Cheng, HH; Cheng, KC; Huang, HC; Shieh, CC; Yu, WL | 1 |
| Becq-Giraudon, B; Breton, I; Burucoa, C; Fauchère, JL; Ramassamy, A; Soyer, J | 1 |
| Kobayashi, H; Kodama, K; Ogawa, K; Ohkawara, A; Shimizu, T; Taniguchi, S | 1 |
| Badsha, H; Chong, AP; Kong, KO; Teh, CL | 1 |
11 other study(ies) available for clarithromycin and Libman-Sacks Disease
| Article | Year |
|---|---|
Case of atypical cutaneous
Topics: Aged; Anti-Bacterial Agents; Clarithromycin; Cyclophosphamide; Diagnosis, Differential; Female; Humans; Imipenem; Immunocompromised Host; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Skin Diseases, Bacterial; Tobramycin; Treatment Outcome | 2019 |
Non-tuberculosis Mycobacterium Tenosynovitis with Rice Bodies in a Patient with Systemic Lupus Erythematosus.
Topics: Adult; Anti-Bacterial Agents; Clarithromycin; Female; Fingers; Humans; Lupus Erythematosus, Systemic; Magnetic Resonance Imaging; Moxifloxacin; Mycobacterium Infections; Symptom Flare Up; Tenosynovitis | 2020 |
Intractable Cutaneous Nontuberculous Mycobacteriosis (Mycobacterium abscessus) during Treatment for Systemic Lupus Erythematosus.
Topics: Adult; Anti-Bacterial Agents; Clarithromycin; Female; Humans; Immunocompromised Host; Lupus Erythematosus, Systemic; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Treatment Outcome | 2017 |
Non-tuberculous mycobacterium bacteraemia in a pregnant systemic lupus erythematosus (SLE) patient: a case review and pooled case analysis.
Topics: Adult; Anti-Bacterial Agents; Bacteremia; Ciprofloxacin; Clarithromycin; Female; Humans; Lupus Erythematosus, Systemic; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Pregnancy; Treatment Outcome | 2018 |
[Obstructive pneumonia and brain abscess due to Nocardia elegans in a patient with systemic lupus erythematosus].
Topics: Aged; Brain Abscess; Clarithromycin; Humans; Lupus Erythematosus, Systemic; Male; Nocardia Infections; Trimethoprim, Sulfamethoxazole Drug Combination | 2014 |
Atypical mycobacteria infection in an immunocompromised patient.
Topics: Anti-Bacterial Agents; Biopsy; Buttocks; Clarithromycin; Female; Hand; Humans; Immunocompromised Host; Lupus Erythematosus, Systemic; Middle Aged; Mycobacterium Infections, Nontuberculous; Sjogren's Syndrome; Skin Diseases; Thigh; Treatment Outcome | 2010 |
Epithelioid histiocytic infiltrate caused by Mycobacterium scrofulaceum infection: a potential mimic of various neoplastic entities.
Topics: Anti-Bacterial Agents; Clarithromycin; Diagnosis, Differential; Female; Histiocytosis; Humans; Immunocompromised Host; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Middle Aged; Mycobacterium Infections, Nontuberculous; Mycobacterium scrofulaceum; Prednisone; Skin Diseases, Bacterial; Skin Neoplasms | 2013 |
Unusual mixed infection of thoracic empyema caused by Mycobacteria tuberculosis, nontuberculosis mycobacteria and Nocardia asteroides in a woman with systemic lupus erythematosus.
Topics: Antitubercular Agents; Clarithromycin; Drug Therapy, Combination; Empyema, Pleural; Empyema, Tuberculous; Female; Humans; Immunocompromised Host; Immunoglobulins, Intravenous; Lupus Erythematosus, Systemic; Middle Aged; Mycobacterium; Nocardia asteroides; Taiwan; Trimethoprim, Sulfamethoxazole Drug Combination | 2007 |
Western blot monitoring of disseminated Nocardia nova infection treated with clarithromycin, imipenem, and surgical drainage.
Topics: Anti-Bacterial Agents; Antigens, Bacterial; Blotting, Western; Clarithromycin; Drug Therapy, Combination; Glucocorticoids; Humans; Imipenem; Immunocompromised Host; Lupus Erythematosus, Systemic; Male; Middle Aged; Nocardia; Nocardia Infections; Prednisone; Thienamycins | 1996 |
Successful treatment using clarithromycin for a cutaneous lesion caused by Mycobacterium szulgai.
Topics: Adult; Anti-Bacterial Agents; Clarithromycin; Female; Humans; Immunosuppression Therapy; Lupus Erythematosus, Systemic; Mycobacterium Infections, Nontuberculous; Skin Diseases, Bacterial | 2000 |
Mycobacterium haemophilum infection in an SLE patient on mycophenolate mofetil.
Topics: Adult; Anti-Bacterial Agents; Antirheumatic Agents; Clarithromycin; Cyclophosphamide; Ethambutol; Female; Humans; Immunosuppressive Agents; Isoniazid; Leg; Lupus Erythematosus, Systemic; Muscle, Skeletal; Mycobacterium haemophilum; Mycobacterium Infections; Mycophenolic Acid; Rifampin | 2002 |